Ładuje się......
Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. The disease is induced by antibodies, which are directed against the podocyte protein phospholipase A(2) receptor 1 (PLA(2)R1-ab) in 80% of cases. B cell depleting treatments, most notably rituximab, a chimeric CD20-antib...
Zapisane w:
| Wydane w: | J Nephrol |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer International Publishing
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036191/ https://ncbi.nlm.nih.gov/pubmed/33026632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-020-00874-2 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|